Covid-19 roundup: US buys 50M Pfiz­er pe­di­atric dos­es; Vir and GSK pub­lish mAb da­ta in NE­JM

More vac­cine dos­es are on the way as pe­di­atric vac­cines could be­gin to roll out as ear­ly as next week.

The US on Thurs­day pur­chased 50 mil­lion more dos­es of the Pfiz­er/BioN­Tech Covid-19 vac­cine, as part of ef­forts to sup­port pre­pared­ness for all pe­di­atric vac­ci­na­tions, in­clud­ing for chil­dren un­der 5 years of age, pend­ing au­tho­riza­tion. The com­pa­nies said they ex­pect to de­liv­er the dos­es by April 30, 2022. Ini­tial da­ta on the vac­cine for the youngest kids, down to 6 months, are ex­pect­ed as soon as the fourth quar­ter of this year or ear­ly first quar­ter 2022.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER